LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

Accueil・Liste d'Actions・Alcon Inc

Alcon Inc

Fermé

SecteurSoins de santé

63.61 -0.59

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

63.45

Max

64.93

Chiffres clés
By Trading Economics
Revenu	-32M 185M
Ventes	-65M 2.7B
P/E Moyenne du Secteur	37.138 51.415
BPA	0.85
Rendement du dividende	0.58
Marge bénéficiaire	6.984
Employés	25,000
EBITDA	168M 689M

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	+43.16% upside

Dividendes
By Dow Jones
Rendement du dividende Moyenne du Secteur	0.58% 2.34%
Prochains Résultats	10 août 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-6.5B 30B
Ouverture précédente	64.2
Clôture précédente	63.61

Sentiment de l'Actualité

By Acuity

50%

155 / 345 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bullish Evidence

95.77 / 97.61 Support & Résistance

Alcon Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

17 mars 2026, 14:42 UTC

Principaux Mouvements du Marché

Acquisitions, Fusions, Rachats

Lensar Share Slide on Terminated Merger Deal With Alcon

16 mars 2026, 21:37 UTC

Acquisitions, Fusions, Rachats

Lensar and Alcon Agree to Terminate Merger

6 janv. 2026, 15:11 UTC

Acquisitions, Fusions, Rachats

Staar Surgical Shareholders Reject $1.6 Billion Acquisition by Alcon in Activist Win

9 déc. 2025, 18:51 UTC

Acquisitions, Fusions, Rachats

Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical

9 déc. 2025, 15:54 UTC

Principaux Mouvements du Marché

Acquisitions, Fusions, Rachats

Staar Surgical Shares Surge as Alcon Boosts its Buyout Price

9 déc. 2025, 14:32 UTC

Acquisitions, Fusions, Rachats

Alcon Upgrades Offer Price for Staar Surgical

5 mai 2026, 21:25 UTC

Résultats

Alcon Inc. 1Q EPS 39c >ALC.EB

5 mai 2026, 21:25 UTC

Résultats

Alcon Inc. 1Q Rev $2.71B >ALC.EB

16 mars 2026, 20:59 UTC

Acquisitions, Fusions, Rachats

Alcon: Transaction Unattractive to Pursue Further in Light of FTC's Opposition

16 mars 2026, 20:59 UTC

Acquisitions, Fusions, Rachats

Alcon: Delay and Associated Costs of Extended Regulatory Review Has Rendered Deal Unattractive to Pursue Further

16 mars 2026, 20:59 UTC

Acquisitions, Fusions, Rachats

Alcon Entered Agreement With LENSAR to Terminate Merger Agreement

16 mars 2026, 20:57 UTC

Acquisitions, Fusions, Rachats

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

25 févr. 2026, 22:29 UTC

Acquisitions, Fusions, Rachats

Lensar Expects to Close Transaction in 1H of 2026 >LNSR

25 févr. 2026, 22:29 UTC

Acquisitions, Fusions, Rachats

Lensar, Alcon Continue to Cooperate With FTC in Connection With Request for Additional Info >LNSR

25 févr. 2026, 22:28 UTC

Acquisitions, Fusions, Rachats

LENSAR Provides Update on Pending Acquisition by Alcon

24 févr. 2026, 21:41 UTC

Résultats

Alcon 4Q Rev $2.72B >ALC.EB

7 janv. 2026, 01:00 UTC

Acquisitions, Fusions, Rachats

Alcon Terminates Agreement To Acquire STAAR Surgical >ALC

6 janv. 2026, 22:03 UTC

Acquisitions, Fusions, Rachats

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6 janv. 2026, 22:03 UTC

Acquisitions, Fusions, Rachats

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6 janv. 2026, 15:21 UTC

Market Talk

Acquisitions, Fusions, Rachats

Staar May See Management Turnover After Alcon Bid Is Rejected -- Market Talk

6 janv. 2026, 14:56 UTC

Acquisitions, Fusions, Rachats

Staar Surgical Shareholders Reject $1.6B Acquisition by Alcon in Activist Win

6 janv. 2026, 14:14 UTC

Acquisitions, Fusions, Rachats

Staar Surgical: Will Remain a Standalone, Publicly Traded Co and Continue to Trade on Nasdaq >STAA

6 janv. 2026, 14:14 UTC

Acquisitions, Fusions, Rachats

Staar Surgical: No Termination Fee Will Be Payable by Either Party >STAA

6 janv. 2026, 14:14 UTC

Acquisitions, Fusions, Rachats

Staar Surgical: Intend to Terminate Merger Agreement With Alcon >STAA

6 janv. 2026, 14:13 UTC

Acquisitions, Fusions, Rachats

Staar Surgical: Did Not Receive Necessary Stockholder Votes to Approve Merger Agreement With Alcon >STAA

9 déc. 2025, 14:17 UTC

Acquisitions, Fusions, Rachats

Alcon Ups Offer Price for Staar Surgical

9 déc. 2025, 13:34 UTC

Acquisitions, Fusions, Rachats

Alcon: Transaction Now Represents a Total Equity Value of $1.6B >ALC.EB

9 déc. 2025, 13:33 UTC

Acquisitions, Fusions, Rachats

Alcon: Purchase Price Increase Represents an Additional $150M >ALC.EB

9 déc. 2025, 13:33 UTC

Acquisitions, Fusions, Rachats

Alcon: Under the Terms of the Amended Agreement, Alcon Will Purchase All Outstanding Shrs of STAAR for $30.75 Per Shr in Cash >ALC.EB

9 déc. 2025, 13:33 UTC

Acquisitions, Fusions, Rachats

Alcon To Finance Transaction Through Issuance of Short- and Long-Term Credit Facilities >ALC

Comparaison

Variation de prix

Alcon Inc prévision

Objectif de Prix

By TipRanks

43.16% hausse

Prévisions sur 12 Mois

Moyen 91.62 USD 43.16%

Haut 109.476 USD

Bas 63.649 USD

Basé sur 16 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

16 ratings

Achat

Maintien

Vente

Basé sur 16 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Score Technique

By Trading Central

95.77 / 97.61Support & Résistance

Bullish events outweigh bearish events.

All events are bullish.

Sentiment

By Acuity

155 / 345Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Alcon Inc

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.